| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3192608 | Annals of Allergy, Asthma & Immunology | 2009 | 9 Pages |
Abstract
Use of TAA AQ, 110 μg once daily, for up to 6 months offers a favorable efficacy to safety ratio in children aged 2 to 5 years with perennial AR.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Steven MD, Paul MD, George MD, FCCP, Anjuli MD,